7D5V

Structure of the C646A mutant of peptidylarginine deiminase type III (PAD3)

7D5V の概要

• エントリーDOI: 10.2210/pdb7d5v/pdb
• 関連するPDBエントリー: 7D4Y 7D56 7D5R
• 分子名称: Protein-arginine deiminase type-3, 1,2-ETHANEDIOL, GLYCEROL, ... (4 entities in total)
• 機能のキーワード: peptidylarginine deiminase, isozyme, mutant, citrullination, post-translational modification, enzyme, cytosolic protein, hydrolase
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 151882.53

構造登録者

Akimoto, M.,Mashimo, R.,Unno, M. (登録日: 2020-09-28, 公開日: 2021-06-02, 最終更新日: 2023-11-29)

主引用文献

Funabashi, K.,Sawata, M.,Nagai, A.,Akimoto, M.,Mashimo, R.,Takahara, H.,Kizawa, K.,Thompson, P.R.,Ite, K.,Kitanishi, K.,Unno, M.
Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
Arch.Biochem.Biophys., 708:108911-108911, 2021

PubMed Abstract: Peptidylarginine deiminase type III (PAD3) is an isozyme belonging to the PAD enzyme family that converts arginine to citrulline residue(s) within proteins. PAD3 is expressed in most differentiated keratinocytes of the epidermis and hair follicles, while S100A3, trichohyalin, and filaggrin are its principal substrates. In this study, the X-ray crystal structures of PAD3 in six states, including its complex with the PAD inhibitor Cl-amidine, were determined. This structural analysis identified a large space around Gly374 in the PAD3-Ca-Cl-amidine complex, which may be used to develop novel PAD3-selective inhibitors. In addition, similarities between PAD3 and PAD4 were found based on the investigation of PAD4 reactivity with S100A3 in vitro. A comparison of the structures of PAD1, PAD2, PAD3, and PAD4 implied that the flexibility of the structures around the active site may lead to different substrate selectivity among these PAD isozymes.

PubMed: 33971157
DOI: 10.1016/j.abb.2021.108911

実験手法

X-RAY DIFFRACTION (2.102 Å)